Functional expression of transgenic 1sDHPR channels in adult mammalian skeletal muscle fibres.
We investigated the effects of the overexpression of two enhanced green fluorescent protein (EGFP)-tagged α1sDHPR variants on Ca2+ currents (ICa), charge movements (Q) and SR Ca2+ release of muscle fibres isolated from adult mice. Flexor digitorum brevis (FDB)muscles were transfected by in vivo electroporation with plasmids encoding for EGFP-α1sDHPR-wt and EGFP-α1sDHPR-T935Y (an isradipine-insensitive mutant). Two-photon laser scanning microscopy (TPLSM) was used to study the subcellular localization of transgenic proteins, while ICa, Q and Ca2+ release were studied electrophysiologically and optically under voltage-clamp conditions. TPLSM images demonstrated that most of the transgenic α1sDHPR was correctly targeted to the transverse tubular system (TTS). Immunoblotting analysis of crude extracts of transfected fibres demonstrated the synthesis of bona fide transgenic EGFP-α1sDHPR-wt in quantities comparable to that of native α1sDHPR. Though expression of both transgenic variants of the alpha subunit of the dihydropyridine receptor (α1sDHPR) resulted in ∼50% increase in Q, they surprisingly had no effect on the maximal Ca2+ conductance (gCa) nor the SR Ca2+ release. Nonetheless, fibres expressing EGFP-α1sDHPR-T935Y exhibited up to 70% isradipine-insensitive ICa (ICa-ins) with a right-shifted voltage dependence compared to that in control fibres. Interestingly, Qand SRCa2+ release also displayed right-shifted voltage dependence in fibres expressing EGFP-α1sDHPR-T935Y. In contrast, the midpoints of the voltage dependence of gCa, Q and Ca2+ release were not different from those in control fibres and in fibres expressing EGFP-α1sDHPR-wt. Overall, our results suggest that transgenic α1sDHPRs are correctly trafficked and inserted in the TTS membrane, and that a substantial fraction of the mworks as conductive Ca2+ channels capable of physiologically controlling the release of Ca2+ from the SR. A plausible corollary of this work is that the expression of transgenic variants of the α1sDHPR leads to the replacement of native channels interacting with the ryanodine receptor 1 (RyR1), thus demonstrating the feasibility of molecular remodelling of the triads in adult skeletal muscle fibres.
Department of Physiology, David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1751, USA.
Marino
M
DiFranco
Philip
P
Tran
Marbella
M
Quiñonez
Julio L
JL
Vergara
D000367:Age Factors; D000818:Animals; D005786:Gene Expression Regulation; D014644:Genetic Variation / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018485:Muscle Fibers, Skeletal / Q000378:metabolism*; D021122:Protein Subunits / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D019837:Ryanodine Receptor Calcium Release Channel / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D019076:Transgenes / Q000502:physiology*
D021122:Protein Subunits; D019837:Ryanodine Receptor Calcium Release Channel
J Gen Physiol. 2006 Jun;127(6):623-37
16735751
Biochem Biophys Res Commun. 2005 Apr 8;329(2):749-54
15737650
Pflugers Arch. 2002 Feb;443(4):508-19
11907817
J Physiol. 2005 Nov 1;568(Pt 3):867-80
16123111
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10778-82
1720551
J Physiol. 2004 May 15;557(Pt 1):59-75
15004213
J Gen Physiol. 2011 Jan;137(1):21-41
21149546
Biophys J. 2001 May;80(5):2046-55
11325708
J Cell Biol. 1998 Feb 23;140(4):831-42
9472035
Biophys J. 1997 Aug;73(2):807-18
9251797
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1903-8
9465115
Biophys J. 1999 Sep;77(3):1528-39
10465763
Nature. 1976 Feb 26;259(5545):684-6
1250422
J Biol Chem. 1997 Jan 31;272(5):2629-33
9006896
Biophys J. 2003 Aug;85(2):1080-97
12885654
Philos Trans R Soc Lond B Biol Sci. 1975 Jun 10;270(908):301-18
238230
Nature. 1994 Jun 16;369(6481):556-9
7515481
EMBO J. 1995 Jul 3;14(13):2999-3006
7621815
Nature. 1991 Aug 29;352(6338):800-3
1652692
Biophys J. 2003 Jan;84(1):251-65
12524279
Nature. 1987 Feb 19-25;325(6106):717-20
2434854
Biophys J. 1999 Nov;77(5):2709-16
10545370
J Biomed Opt. 2004 Sep-Oct;9(5):882-92
15447009
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6935-40
11371610
Physiol Rev. 1991 Jul;71(3):849-908
2057528
J Biol Chem. 1987 Jun 15;262(17):7943-6
2439496
J Physiol. 2004 Feb 15;555(Pt 1):251-65
14594987
Annu Rev Cell Dev Biol. 2000;16:521-55
11031246
Pflugers Arch. 1997 Sep;434(5):615-31
9242727
Am J Physiol Cell Physiol. 2010 May;298(5):C1077-86
20130206
Front Biosci. 2002 Mar 01;7:d659-70
11861208
Nature. 1988 Nov 10;336(6195):134-9
2903448
J Cell Biol. 1989 Jul;109(1):135-47
2545725
Biophys J. 2000 Dec;79(6):3009-18
11106608
Am J Physiol Cell Physiol. 2005 Mar;288(3):C640-9
15548569
J Vis Exp. 2009 Oct 19;(32):
19841615
FASEB J. 1990 Jul;4(10):2809-16
2165014
Channels (Austin). 2009 Jul-Aug;3(4):268-73
19625771
J Physiol. 2009 Sep 15;587(Pt 18):4543-59
19651766
Nature. 1990 Mar 29;344(6265):451-3
2157159
J Gen Physiol. 2004 Nov;124(5):605-18
15504904
Eur Biophys J. 2009 Dec;39(1):75-81
19455319
J Biol Chem. 2005 Jan 21;280(3):2229-37
15536090
Eur J Pharmacol. 2007 Jun 22;565(1-3):7-16
17397827
Nature. 1990 Aug 9;346(6284):567-9
2165570
J Physiol. 2005 Jan 15;562(Pt 2):347-65
15528246
J Membr Biol. 2005 Nov;208(2):141-53
16645743
J Biol Chem. 1997 Mar 14;272(11):7360-7
9054435
J Muscle Res Cell Motil. 2006;27(8):545-58
16823602
Handb Exp Pharmacol. 2007;(178):441-68
17203666
Nature. 1991 Aug 8;352(6335):527-30
1650913
J Gen Physiol. 1988 Jun;91(6):781-98
2458429
Protein Expr Purif. 2006 May;47(1):281-8
16325422
Ann N Y Acad Sci. 1988;522:134-49
2454048
J Gen Physiol. 2007 Dec;130(6):581-600
18040060
J Gen Physiol. 1978 Dec;72(6):775-800
310445
J Biol Chem. 1996 Nov 29;271(48):30330-5
8939992
J Physiol. 1999 Jun 15;517 ( Pt 3):757-70
10358116